Analyst Price Targets — OMDA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 8, 2026 1:15 pm | Elizabeth Anderson | Evercore ISI | $15.00 | $12.53 | TheFly | Omada Health price target lowered to $15 from $20 at Evercore ISI |
| January 16, 2026 12:00 pm | David Roman | Goldman Sachs | $26.00 | $15.65 | TheFly | Omada Health price target lowered to $26 from $29 at Goldman Sachs |
| January 9, 2026 10:52 am | — | Goldman Sachs | $29.00 | $16.44 | TheFly | Omada Health price target lowered to $29 from $33 at Goldman Sachs |
| January 8, 2026 9:19 pm | — | Wells Fargo | $17.00 | $16.44 | TheFly | Omada Health initiated with an Equal Weight at Wells Fargo |
| January 5, 2026 11:46 am | Saket Kalia | Barclays | $22.00 | $14.90 | TheFly | Omada Health price target lowered to $22 from $29 at Barclays |
| December 18, 2025 12:58 pm | — | Morgan Stanley | $32.00 | $14.62 | TheFly | Omada Health named Top Pick in Healthcare Technology at Morgan Stanley |
| October 8, 2025 12:16 pm | Elizabeth Anderson | Evercore ISI | $27.00 | $25.00 | TheFly | Omada Health added to 'Tactical Outperform' list at Evercore ISI |
| September 5, 2025 9:46 am | — | Robert W. Baird | $24.00 | $24.28 | TheFly | Omada Health initiated with a Neutral at Baird |
| July 1, 2025 10:39 am | — | Needham | $23.00 | $18.25 | TheFly | Omada Health initiated with a Buy at Needham |
Latest News for OMDA
SAN FRANCISCO, April 17, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first provider of between-visit care, announced new study results demonstrating that Omada members in its GLP-1 Care Track lost, on average, 1.8 times more total weight and reduced their body fat percentage twice as much as the comparison group.1 The Omada members also saw an increase in muscle mass percentage and improvements…
SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its first quarter 2026 results on Thursday, May 7, 2026, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details A live audio webcast of the call will be available online at…
Shares of Omada Health, Inc. (NASDAQ: OMDA - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eleven research firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have given a buy rating
The average of price targets set by Wall Street analysts indicates a potential upside of 59.5% in Omada Health, Inc. (OMDA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Omada Health's digital healthcare platform helps patients between doctors visits, improving outcomes. A growing trove of data shows the company's success in improving its members' health -- especially those on GLP-1s.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for OMDA.
U.S. House Trading
No House trades found for OMDA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.